SF3B1 and prostate cancer: However, the pathological importance of SF3B1 does not only rely on the well characterized role of SF3B1 mutations, but growing evidence indicates that alteration of its expression can also have malignant consequences in some cancers, such as prostate cancer [16] and hepatocarcinoma [17].